The results indicate that Nr-CWS, as an immunotherapeutic agent for HR-HPV infection and CIN, plays an immune promoting role related to the upregulation of T cell subsets and the inhibition of PD-1/PD-L1 pathway. This evidence concerns the gene PDCD1 and cervical squamous intraepithelial neoplasia.